Biomanufacturing company Multiply Labs is using Nvidia technologies to develop robotic biomanufacturing systems for ...

Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies; The company is now leveraging NVIDIA's open ...

Collaboration with AstraZeneca will focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic ...

Multiply Labs' goal is to enable scalable, high-throughput manufacturing while maintaining rigorous quality and regulatory standards.

To evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing.

Breakthrough partnership with Universal Robots transforms "artisanal" manufacturing, making personalized, life-saving cancer treatments affordable and widely available. Leveraging collaborative robots ...

Teradyne, Inc. (NASDAQ:TER) is one of the 10 Best Semiconductor Stocks to Buy Right Now. On August 21, it was announced that Multiply Labs developed a new robotic biomanufacturing cluster, which ...

Opportunities in the Global Pharmaceutical Collaborative Robots Market include enhancing operational efficiency, reducing ...

Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies; The company is now leveraging NVIDIA’s open ...